| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3370100 | Journal of Clinical Virology | 2008 | 5 Pages |
Abstract
Occult HBV did not increase the incidence of hepatic transaminitis over 2 years. Future studies should determine whether occult HBV is associated with other clinically important outcomes, particularly hepatocellular carcinoma.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Vincent III, Benjamin Wertheimer, A. Russell Localio, Jay R. Kostman, Janel Dockter, Jeffrey M. Linnen, Cristina Giachetti, Zachariah Dorey-Stein, Ian Frank, Brian L. Strom, Robert Gross,